nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—CYP2A6—Prednisolone—psoriatic arthritis	0.0993	0.123	CbGbCtD
Buprenorphine—CYP2A6—Dexamethasone—psoriatic arthritis	0.0585	0.0726	CbGbCtD
Buprenorphine—ABCG2—Dexamethasone—psoriatic arthritis	0.0542	0.0672	CbGbCtD
Buprenorphine—ABCB1—Methylprednisolone—psoriatic arthritis	0.0517	0.0641	CbGbCtD
Buprenorphine—ABCG2—Methotrexate—psoriatic arthritis	0.0435	0.054	CbGbCtD
Buprenorphine—CYP3A7—Dexamethasone—psoriatic arthritis	0.04	0.0497	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.04	0.0497	CbGbCtD
Buprenorphine—CYP2C19—Prednisone—psoriatic arthritis	0.0388	0.0481	CbGbCtD
Buprenorphine—ABCB1—Betamethasone—psoriatic arthritis	0.0336	0.0417	CbGbCtD
Buprenorphine—ABCB1—Prednisolone—psoriatic arthritis	0.0331	0.0411	CbGbCtD
Buprenorphine—ABCB1—Prednisone—psoriatic arthritis	0.0313	0.0388	CbGbCtD
Buprenorphine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0309	0.0384	CbGbCtD
Buprenorphine—CYP3A5—Dexamethasone—psoriatic arthritis	0.03	0.0373	CbGbCtD
Buprenorphine—CYP2C8—Dexamethasone—psoriatic arthritis	0.0289	0.0358	CbGbCtD
Buprenorphine—CYP2C19—Dexamethasone—psoriatic arthritis	0.0242	0.03	CbGbCtD
Buprenorphine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0235	0.0291	CbGbCtD
Buprenorphine—CYP2C9—Dexamethasone—psoriatic arthritis	0.0201	0.025	CbGbCtD
Buprenorphine—CYP3A4—Betamethasone—psoriatic arthritis	0.0201	0.025	CbGbCtD
Buprenorphine—CYP3A4—Prednisolone—psoriatic arthritis	0.0199	0.0246	CbGbCtD
Buprenorphine—ABCB1—Dexamethasone—psoriatic arthritis	0.0195	0.0242	CbGbCtD
Buprenorphine—CYP3A4—Prednisone—psoriatic arthritis	0.0188	0.0233	CbGbCtD
Buprenorphine—CYP2D6—Dexamethasone—psoriatic arthritis	0.0184	0.0228	CbGbCtD
Buprenorphine—ABCB1—Methotrexate—psoriatic arthritis	0.0157	0.0195	CbGbCtD
Buprenorphine—CYP3A4—Dexamethasone—psoriatic arthritis	0.0117	0.0145	CbGbCtD
Buprenorphine—Vertigo—Dexamethasone—psoriatic arthritis	0.000298	0.00153	CcSEcCtD
Buprenorphine—Vertigo—Betamethasone—psoriatic arthritis	0.000298	0.00153	CcSEcCtD
Buprenorphine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000297	0.00153	CcSEcCtD
Buprenorphine—Syncope—Dexamethasone—psoriatic arthritis	0.000297	0.00153	CcSEcCtD
Buprenorphine—Syncope—Betamethasone—psoriatic arthritis	0.000297	0.00153	CcSEcCtD
Buprenorphine—Infection—Triamcinolone—psoriatic arthritis	0.000296	0.00153	CcSEcCtD
Buprenorphine—Sweating—Methotrexate—psoriatic arthritis	0.000296	0.00152	CcSEcCtD
Buprenorphine—Infection—Methylprednisolone—psoriatic arthritis	0.000295	0.00152	CcSEcCtD
Buprenorphine—Shock—Triamcinolone—psoriatic arthritis	0.000293	0.00151	CcSEcCtD
Buprenorphine—Insomnia—Prednisolone—psoriatic arthritis	0.000293	0.00151	CcSEcCtD
Buprenorphine—Shock—Methylprednisolone—psoriatic arthritis	0.000293	0.00151	CcSEcCtD
Buprenorphine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000292	0.0015	CcSEcCtD
Buprenorphine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000292	0.0015	CcSEcCtD
Buprenorphine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000291	0.0015	CcSEcCtD
Buprenorphine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000291	0.0015	CcSEcCtD
Buprenorphine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000291	0.0015	CcSEcCtD
Buprenorphine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000291	0.0015	CcSEcCtD
Buprenorphine—Mental disorder—Prednisone—psoriatic arthritis	0.00029	0.0015	CcSEcCtD
Buprenorphine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00029	0.00149	CcSEcCtD
Buprenorphine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000289	0.00149	CcSEcCtD
Buprenorphine—Erythema—Prednisone—psoriatic arthritis	0.000289	0.00149	CcSEcCtD
Buprenorphine—Malnutrition—Prednisone—psoriatic arthritis	0.000289	0.00149	CcSEcCtD
Buprenorphine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000288	0.00148	CcSEcCtD
Buprenorphine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000288	0.00148	CcSEcCtD
Buprenorphine—Convulsion—Dexamethasone—psoriatic arthritis	0.000287	0.00148	CcSEcCtD
Buprenorphine—Convulsion—Betamethasone—psoriatic arthritis	0.000287	0.00148	CcSEcCtD
Buprenorphine—Hypertension—Betamethasone—psoriatic arthritis	0.000286	0.00147	CcSEcCtD
Buprenorphine—Hypertension—Dexamethasone—psoriatic arthritis	0.000286	0.00147	CcSEcCtD
Buprenorphine—Myalgia—Betamethasone—psoriatic arthritis	0.000282	0.00145	CcSEcCtD
Buprenorphine—Myalgia—Dexamethasone—psoriatic arthritis	0.000282	0.00145	CcSEcCtD
Buprenorphine—Anxiety—Betamethasone—psoriatic arthritis	0.000281	0.00145	CcSEcCtD
Buprenorphine—Anxiety—Dexamethasone—psoriatic arthritis	0.000281	0.00145	CcSEcCtD
Buprenorphine—Discomfort—Betamethasone—psoriatic arthritis	0.000279	0.00144	CcSEcCtD
Buprenorphine—Discomfort—Dexamethasone—psoriatic arthritis	0.000279	0.00144	CcSEcCtD
Buprenorphine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000278	0.00143	CcSEcCtD
Buprenorphine—Pain—Prednisolone—psoriatic arthritis	0.000277	0.00143	CcSEcCtD
Buprenorphine—Pharyngitis—Methotrexate—psoriatic arthritis	0.000275	0.00142	CcSEcCtD
Buprenorphine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000274	0.00141	CcSEcCtD
Buprenorphine—Vision blurred—Prednisone—psoriatic arthritis	0.000272	0.0014	CcSEcCtD
Buprenorphine—Urethral disorder—Methotrexate—psoriatic arthritis	0.000272	0.0014	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000272	0.0014	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000271	0.0014	CcSEcCtD
Buprenorphine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00027	0.00139	CcSEcCtD
Buprenorphine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00027	0.00139	CcSEcCtD
Buprenorphine—Oedema—Betamethasone—psoriatic arthritis	0.00027	0.00139	CcSEcCtD
Buprenorphine—Oedema—Dexamethasone—psoriatic arthritis	0.00027	0.00139	CcSEcCtD
Buprenorphine—Insomnia—Triamcinolone—psoriatic arthritis	0.00027	0.00139	CcSEcCtD
Buprenorphine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000269	0.00139	CcSEcCtD
Buprenorphine—Infection—Dexamethasone—psoriatic arthritis	0.000269	0.00138	CcSEcCtD
Buprenorphine—Infection—Betamethasone—psoriatic arthritis	0.000269	0.00138	CcSEcCtD
Buprenorphine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000268	0.00138	CcSEcCtD
Buprenorphine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000268	0.00138	CcSEcCtD
Buprenorphine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000267	0.00138	CcSEcCtD
Buprenorphine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000267	0.00138	CcSEcCtD
Buprenorphine—Visual impairment—Methotrexate—psoriatic arthritis	0.000267	0.00138	CcSEcCtD
Buprenorphine—Shock—Betamethasone—psoriatic arthritis	0.000266	0.00137	CcSEcCtD
Buprenorphine—Shock—Dexamethasone—psoriatic arthritis	0.000266	0.00137	CcSEcCtD
Buprenorphine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000266	0.00137	CcSEcCtD
Buprenorphine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000265	0.00137	CcSEcCtD
Buprenorphine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000265	0.00137	CcSEcCtD
Buprenorphine—Agitation—Prednisone—psoriatic arthritis	0.000265	0.00137	CcSEcCtD
Buprenorphine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000264	0.00136	CcSEcCtD
Buprenorphine—Tachycardia—Betamethasone—psoriatic arthritis	0.000264	0.00136	CcSEcCtD
Buprenorphine—Angioedema—Prednisone—psoriatic arthritis	0.000264	0.00136	CcSEcCtD
Buprenorphine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000262	0.00135	CcSEcCtD
Buprenorphine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000262	0.00135	CcSEcCtD
Buprenorphine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000261	0.00135	CcSEcCtD
Buprenorphine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000261	0.00135	CcSEcCtD
Buprenorphine—Malaise—Prednisone—psoriatic arthritis	0.00026	0.00134	CcSEcCtD
Buprenorphine—Vertigo—Prednisone—psoriatic arthritis	0.000259	0.00134	CcSEcCtD
Buprenorphine—Eye disorder—Methotrexate—psoriatic arthritis	0.000259	0.00133	CcSEcCtD
Buprenorphine—Syncope—Prednisone—psoriatic arthritis	0.000259	0.00133	CcSEcCtD
Buprenorphine—Tinnitus—Methotrexate—psoriatic arthritis	0.000258	0.00133	CcSEcCtD
Buprenorphine—Anorexia—Betamethasone—psoriatic arthritis	0.000258	0.00133	CcSEcCtD
Buprenorphine—Anorexia—Dexamethasone—psoriatic arthritis	0.000258	0.00133	CcSEcCtD
Buprenorphine—Urticaria—Prednisolone—psoriatic arthritis	0.000257	0.00133	CcSEcCtD
Buprenorphine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000257	0.00132	CcSEcCtD
Buprenorphine—Fatigue—Triamcinolone—psoriatic arthritis	0.000257	0.00132	CcSEcCtD
Buprenorphine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000256	0.00132	CcSEcCtD
Buprenorphine—Pain—Triamcinolone—psoriatic arthritis	0.000255	0.00131	CcSEcCtD
Buprenorphine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000254	0.00131	CcSEcCtD
Buprenorphine—Hypotension—Betamethasone—psoriatic arthritis	0.000253	0.0013	CcSEcCtD
Buprenorphine—Hypotension—Dexamethasone—psoriatic arthritis	0.000253	0.0013	CcSEcCtD
Buprenorphine—Angiopathy—Methotrexate—psoriatic arthritis	0.000251	0.00129	CcSEcCtD
Buprenorphine—Immune system disorder—Methotrexate—psoriatic arthritis	0.00025	0.00129	CcSEcCtD
Buprenorphine—Convulsion—Prednisone—psoriatic arthritis	0.00025	0.00129	CcSEcCtD
Buprenorphine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00025	0.00129	CcSEcCtD
Buprenorphine—Hypertension—Prednisone—psoriatic arthritis	0.000249	0.00128	CcSEcCtD
Buprenorphine—Chills—Methotrexate—psoriatic arthritis	0.000249	0.00128	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000246	0.00127	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000246	0.00127	CcSEcCtD
Buprenorphine—Arthralgia—Prednisone—psoriatic arthritis	0.000246	0.00127	CcSEcCtD
Buprenorphine—Myalgia—Prednisone—psoriatic arthritis	0.000246	0.00127	CcSEcCtD
Buprenorphine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000246	0.00126	CcSEcCtD
Buprenorphine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000245	0.00126	CcSEcCtD
Buprenorphine—Anxiety—Prednisone—psoriatic arthritis	0.000245	0.00126	CcSEcCtD
Buprenorphine—Insomnia—Betamethasone—psoriatic arthritis	0.000245	0.00126	CcSEcCtD
Buprenorphine—Insomnia—Dexamethasone—psoriatic arthritis	0.000245	0.00126	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000244	0.00126	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000243	0.00125	CcSEcCtD
Buprenorphine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000243	0.00125	CcSEcCtD
Buprenorphine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000243	0.00125	CcSEcCtD
Buprenorphine—Discomfort—Prednisone—psoriatic arthritis	0.000243	0.00125	CcSEcCtD
Buprenorphine—Mental disorder—Methotrexate—psoriatic arthritis	0.000243	0.00125	CcSEcCtD
Buprenorphine—Erythema—Methotrexate—psoriatic arthritis	0.000241	0.00124	CcSEcCtD
Buprenorphine—Malnutrition—Methotrexate—psoriatic arthritis	0.000241	0.00124	CcSEcCtD
Buprenorphine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000239	0.00123	CcSEcCtD
Buprenorphine—Dyspepsia—Betamethasone—psoriatic arthritis	0.000238	0.00123	CcSEcCtD
Buprenorphine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000238	0.00123	CcSEcCtD
Buprenorphine—Urticaria—Triamcinolone—psoriatic arthritis	0.000237	0.00122	CcSEcCtD
Buprenorphine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000236	0.00122	CcSEcCtD
Buprenorphine—Dysgeusia—Methotrexate—psoriatic arthritis	0.000236	0.00122	CcSEcCtD
Buprenorphine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000236	0.00121	CcSEcCtD
Buprenorphine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000236	0.00121	CcSEcCtD
Buprenorphine—Oedema—Prednisone—psoriatic arthritis	0.000236	0.00121	CcSEcCtD
Buprenorphine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000235	0.00121	CcSEcCtD
Buprenorphine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000235	0.00121	CcSEcCtD
Buprenorphine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000235	0.00121	CcSEcCtD
Buprenorphine—Infection—Prednisone—psoriatic arthritis	0.000234	0.00121	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000233	0.0012	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000233	0.0012	CcSEcCtD
Buprenorphine—Back pain—Methotrexate—psoriatic arthritis	0.000233	0.0012	CcSEcCtD
Buprenorphine—Fatigue—Dexamethasone—psoriatic arthritis	0.000233	0.0012	CcSEcCtD
Buprenorphine—Fatigue—Betamethasone—psoriatic arthritis	0.000233	0.0012	CcSEcCtD
Buprenorphine—Shock—Prednisone—psoriatic arthritis	0.000232	0.00119	CcSEcCtD
Buprenorphine—Pain—Betamethasone—psoriatic arthritis	0.000231	0.00119	CcSEcCtD
Buprenorphine—Pain—Dexamethasone—psoriatic arthritis	0.000231	0.00119	CcSEcCtD
Buprenorphine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000231	0.00119	CcSEcCtD
Buprenorphine—Tachycardia—Prednisone—psoriatic arthritis	0.00023	0.00118	CcSEcCtD
Buprenorphine—Skin disorder—Prednisone—psoriatic arthritis	0.000229	0.00118	CcSEcCtD
Buprenorphine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000228	0.00117	CcSEcCtD
Buprenorphine—Vision blurred—Methotrexate—psoriatic arthritis	0.000227	0.00117	CcSEcCtD
Buprenorphine—Anorexia—Prednisone—psoriatic arthritis	0.000225	0.00116	CcSEcCtD
Buprenorphine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000224	0.00115	CcSEcCtD
Buprenorphine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000223	0.00115	CcSEcCtD
Buprenorphine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000223	0.00115	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000221	0.00114	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000221	0.00114	CcSEcCtD
Buprenorphine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00022	0.00113	CcSEcCtD
Buprenorphine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000219	0.00113	CcSEcCtD
Buprenorphine—Malaise—Methotrexate—psoriatic arthritis	0.000217	0.00112	CcSEcCtD
Buprenorphine—Vertigo—Methotrexate—psoriatic arthritis	0.000217	0.00112	CcSEcCtD
Buprenorphine—Urticaria—Dexamethasone—psoriatic arthritis	0.000215	0.00111	CcSEcCtD
Buprenorphine—Urticaria—Betamethasone—psoriatic arthritis	0.000215	0.00111	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000215	0.00111	CcSEcCtD
Buprenorphine—Dizziness—Prednisolone—psoriatic arthritis	0.000214	0.0011	CcSEcCtD
Buprenorphine—Asthenia—Triamcinolone—psoriatic arthritis	0.000214	0.0011	CcSEcCtD
Buprenorphine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000214	0.0011	CcSEcCtD
Buprenorphine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000214	0.0011	CcSEcCtD
Buprenorphine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000214	0.0011	CcSEcCtD
Buprenorphine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000214	0.0011	CcSEcCtD
Buprenorphine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000213	0.0011	CcSEcCtD
Buprenorphine—Insomnia—Prednisone—psoriatic arthritis	0.000213	0.0011	CcSEcCtD
Buprenorphine—Paraesthesia—Prednisone—psoriatic arthritis	0.000211	0.00109	CcSEcCtD
Buprenorphine—Pruritus—Triamcinolone—psoriatic arthritis	0.000211	0.00109	CcSEcCtD
Buprenorphine—Cough—Methotrexate—psoriatic arthritis	0.00021	0.00108	CcSEcCtD
Buprenorphine—Pruritus—Methylprednisolone—psoriatic arthritis	0.00021	0.00108	CcSEcCtD
Buprenorphine—Convulsion—Methotrexate—psoriatic arthritis	0.000209	0.00108	CcSEcCtD
Buprenorphine—Dyspepsia—Prednisone—psoriatic arthritis	0.000207	0.00107	CcSEcCtD
Buprenorphine—Chest pain—Methotrexate—psoriatic arthritis	0.000205	0.00106	CcSEcCtD
Buprenorphine—Myalgia—Methotrexate—psoriatic arthritis	0.000205	0.00106	CcSEcCtD
Buprenorphine—Arthralgia—Methotrexate—psoriatic arthritis	0.000205	0.00106	CcSEcCtD
Buprenorphine—Decreased appetite—Prednisone—psoriatic arthritis	0.000205	0.00105	CcSEcCtD
Buprenorphine—Rash—Prednisolone—psoriatic arthritis	0.000204	0.00105	CcSEcCtD
Buprenorphine—Dermatitis—Prednisolone—psoriatic arthritis	0.000204	0.00105	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000204	0.00105	CcSEcCtD
Buprenorphine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000203	0.00105	CcSEcCtD
Buprenorphine—Fatigue—Prednisone—psoriatic arthritis	0.000203	0.00105	CcSEcCtD
Buprenorphine—Headache—Prednisolone—psoriatic arthritis	0.000203	0.00105	CcSEcCtD
Buprenorphine—Discomfort—Methotrexate—psoriatic arthritis	0.000203	0.00104	CcSEcCtD
Buprenorphine—Constipation—Prednisone—psoriatic arthritis	0.000201	0.00104	CcSEcCtD
Buprenorphine—Confusional state—Methotrexate—psoriatic arthritis	0.000198	0.00102	CcSEcCtD
Buprenorphine—Dizziness—Triamcinolone—psoriatic arthritis	0.000197	0.00102	CcSEcCtD
Buprenorphine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000197	0.00101	CcSEcCtD
Buprenorphine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000197	0.00101	CcSEcCtD
Buprenorphine—Infection—Methotrexate—psoriatic arthritis	0.000196	0.00101	CcSEcCtD
Buprenorphine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000194	0.001	CcSEcCtD
Buprenorphine—Asthenia—Dexamethasone—psoriatic arthritis	0.000194	0.000999	CcSEcCtD
Buprenorphine—Asthenia—Betamethasone—psoriatic arthritis	0.000194	0.000999	CcSEcCtD
Buprenorphine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000193	0.000994	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000193	0.000992	CcSEcCtD
Buprenorphine—Nausea—Prednisolone—psoriatic arthritis	0.000193	0.000991	CcSEcCtD
Buprenorphine—Pruritus—Betamethasone—psoriatic arthritis	0.000191	0.000985	CcSEcCtD
Buprenorphine—Pruritus—Dexamethasone—psoriatic arthritis	0.000191	0.000985	CcSEcCtD
Buprenorphine—Skin disorder—Methotrexate—psoriatic arthritis	0.000191	0.000985	CcSEcCtD
Buprenorphine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00019	0.00098	CcSEcCtD
Buprenorphine—Vomiting—Triamcinolone—psoriatic arthritis	0.00019	0.000976	CcSEcCtD
Buprenorphine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000189	0.000974	CcSEcCtD
Buprenorphine—Rash—Triamcinolone—psoriatic arthritis	0.000188	0.000968	CcSEcCtD
Buprenorphine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000188	0.000967	CcSEcCtD
Buprenorphine—Anorexia—Methotrexate—psoriatic arthritis	0.000188	0.000966	CcSEcCtD
Buprenorphine—Rash—Methylprednisolone—psoriatic arthritis	0.000188	0.000966	CcSEcCtD
Buprenorphine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000187	0.000965	CcSEcCtD
Buprenorphine—Urticaria—Prednisone—psoriatic arthritis	0.000187	0.000964	CcSEcCtD
Buprenorphine—Headache—Triamcinolone—psoriatic arthritis	0.000187	0.000962	CcSEcCtD
Buprenorphine—Headache—Methylprednisolone—psoriatic arthritis	0.000186	0.00096	CcSEcCtD
Buprenorphine—Body temperature increased—Prednisone—psoriatic arthritis	0.000186	0.000959	CcSEcCtD
Buprenorphine—Abdominal pain—Prednisone—psoriatic arthritis	0.000186	0.000959	CcSEcCtD
Buprenorphine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000185	0.000953	CcSEcCtD
Buprenorphine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000185	0.000953	CcSEcCtD
Buprenorphine—Hypotension—Methotrexate—psoriatic arthritis	0.000184	0.000947	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000179	0.000924	CcSEcCtD
Buprenorphine—Dizziness—Betamethasone—psoriatic arthritis	0.000179	0.000921	CcSEcCtD
Buprenorphine—Dizziness—Dexamethasone—psoriatic arthritis	0.000179	0.000921	CcSEcCtD
Buprenorphine—Insomnia—Methotrexate—psoriatic arthritis	0.000178	0.000917	CcSEcCtD
Buprenorphine—Nausea—Triamcinolone—psoriatic arthritis	0.000177	0.000912	CcSEcCtD
Buprenorphine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000177	0.00091	CcSEcCtD
Buprenorphine—Nausea—Methylprednisolone—psoriatic arthritis	0.000177	0.00091	CcSEcCtD
Buprenorphine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000175	0.000904	CcSEcCtD
Buprenorphine—Somnolence—Methotrexate—psoriatic arthritis	0.000175	0.000901	CcSEcCtD
Buprenorphine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000174	0.000894	CcSEcCtD
Buprenorphine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000173	0.000892	CcSEcCtD
Buprenorphine—Vomiting—Dexamethasone—psoriatic arthritis	0.000172	0.000886	CcSEcCtD
Buprenorphine—Vomiting—Betamethasone—psoriatic arthritis	0.000172	0.000886	CcSEcCtD
Buprenorphine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000171	0.000881	CcSEcCtD
Buprenorphine—Rash—Betamethasone—psoriatic arthritis	0.000171	0.000878	CcSEcCtD
Buprenorphine—Rash—Dexamethasone—psoriatic arthritis	0.000171	0.000878	CcSEcCtD
Buprenorphine—Dermatitis—Betamethasone—psoriatic arthritis	0.00017	0.000877	CcSEcCtD
Buprenorphine—Dermatitis—Dexamethasone—psoriatic arthritis	0.00017	0.000877	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00017	0.000875	CcSEcCtD
Buprenorphine—Fatigue—Methotrexate—psoriatic arthritis	0.00017	0.000874	CcSEcCtD
Buprenorphine—Headache—Betamethasone—psoriatic arthritis	0.000169	0.000873	CcSEcCtD
Buprenorphine—Headache—Dexamethasone—psoriatic arthritis	0.000169	0.000873	CcSEcCtD
Buprenorphine—Asthenia—Prednisone—psoriatic arthritis	0.000169	0.00087	CcSEcCtD
Buprenorphine—Pain—Methotrexate—psoriatic arthritis	0.000168	0.000867	CcSEcCtD
Buprenorphine—Pruritus—Prednisone—psoriatic arthritis	0.000167	0.000858	CcSEcCtD
Buprenorphine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000162	0.000835	CcSEcCtD
Buprenorphine—Diarrhoea—Prednisone—psoriatic arthritis	0.000161	0.00083	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000161	0.000829	CcSEcCtD
Buprenorphine—Nausea—Betamethasone—psoriatic arthritis	0.000161	0.000827	CcSEcCtD
Buprenorphine—Nausea—Dexamethasone—psoriatic arthritis	0.000161	0.000827	CcSEcCtD
Buprenorphine—Urticaria—Methotrexate—psoriatic arthritis	0.000156	0.000805	CcSEcCtD
Buprenorphine—Dizziness—Prednisone—psoriatic arthritis	0.000156	0.000802	CcSEcCtD
Buprenorphine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000156	0.000801	CcSEcCtD
Buprenorphine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000156	0.000801	CcSEcCtD
Buprenorphine—Vomiting—Prednisone—psoriatic arthritis	0.00015	0.000771	CcSEcCtD
Buprenorphine—Rash—Prednisone—psoriatic arthritis	0.000149	0.000765	CcSEcCtD
Buprenorphine—Dermatitis—Prednisone—psoriatic arthritis	0.000148	0.000764	CcSEcCtD
Buprenorphine—Headache—Prednisone—psoriatic arthritis	0.000148	0.00076	CcSEcCtD
Buprenorphine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000145	0.000747	CcSEcCtD
Buprenorphine—Asthenia—Methotrexate—psoriatic arthritis	0.000141	0.000727	CcSEcCtD
Buprenorphine—Nausea—Prednisone—psoriatic arthritis	0.00014	0.00072	CcSEcCtD
Buprenorphine—Pruritus—Methotrexate—psoriatic arthritis	0.000139	0.000717	CcSEcCtD
Buprenorphine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000135	0.000694	CcSEcCtD
Buprenorphine—Dizziness—Methotrexate—psoriatic arthritis	0.00013	0.00067	CcSEcCtD
Buprenorphine—Vomiting—Methotrexate—psoriatic arthritis	0.000125	0.000645	CcSEcCtD
Buprenorphine—Rash—Methotrexate—psoriatic arthritis	0.000124	0.000639	CcSEcCtD
Buprenorphine—Dermatitis—Methotrexate—psoriatic arthritis	0.000124	0.000639	CcSEcCtD
Buprenorphine—Headache—Methotrexate—psoriatic arthritis	0.000123	0.000635	CcSEcCtD
Buprenorphine—Nausea—Methotrexate—psoriatic arthritis	0.000117	0.000602	CcSEcCtD
